Leading the Way in Life Science Technologies

GEN Exclusives

More »
Readers Comments Back to Item »

New Recommendations for Gene Patents - Thank Goodness!

3 Readers' Comments

Posted by: Patent expirations


But patents expire after 20 years. During that 20 years, there are restrictions, but after that, they are free and open. I don't see a problem with that.

Posted by: Asst prof., and author


The consequences of secret-keeping are not so horrifying, as the technology to sequence becomes more widely available and the costs continue to come down. Horror of horrors, the market to commercialize based on these discoveries will actually depend on competition rather than monopoly.

Here's a recent debate I had with Gene Quinn on this subject: http://lauraflanders.firedoglake.com/2009/10/27/who-owns-you-corporations-patenting-your-genes/

Posted by: President Vulvox Inc.


It's possible that protection of patented material in the biotechnology industry is no longer guaranteed and that that has caused the devaluation of patents they are talking about. Expect genetic engineering companies that discover gene sequences to keep them secret since they are not patentable. The consequences of that are obvious.

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »